Complex Endovascular Approach to Treatment of Patients With Aneurysm of Popliteal Artery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-01

Study Completion Date

2020-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Use of endovascular techniques - implantation of a peripheral stent graft and a peripheral flexible stent to isolate the sac of the popliteal artery aneurysm from the circulation and subsequent topical application of a thrombolytic (rtPA) to restore patency of the lower leg blood stream - will lead to a comparable or better outcome in treatment of patients with the popliteal artery aneurysm and acute critical limb ischaemia, compared to currently prevailing use of surgical treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Endovascular Treatment of Peripheral Artery Disease (PAD)

NCT03414515

Peripheral Arterial Disease Iliac Artery Disease Femoropopliteal Occlusive Disease +1 more

COMPLETED

IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA

NCT02963649

Critical Limb Ischemia Peripheral Arterial Disease

COMPLETED NA

Drug-Eluting Balloons vs Mimetic Stents for Popliteal Artery Disease

NCT05651165

Popliteal Arterial Stenosis

UNKNOWN NA

DAART vs PTA/SUPERA STENTING FOR POPLITEAL ARTERY LESIONS

NCT05617053

Popliteal Artery Stenosis Atheroma

COMPLETED

PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

NCT00471289

Peripheral Vascular Disease

UNKNOWN PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The 2nd Medical Department admits patients with acute arterial occlusion at the stage of critical limb ischaemia. The poorest prognosis considering preservation of the limb is shown by the patients who exhibit symptoms of ischaemia due to affected popliteal artery and arteries of the shank in the the popliteal artery aneurysm. On the other hand, diagnosis of this condition is prompt and easy (general ultrasound scan below the knee). Patients with the popliteal artery aneurysm, confirmed by ultrasound investigation, and concurrent signs and symptoms of acute critical ischaemia will be indicated for catheterization intervention at our unit, which will confirm morphological compatibility with endovascular occlusion of the aneurysm sac through implantation of a peripheral stent graft, supported by implantation of a peripheral flexible stent, and at the same time insertion of a thrombolytic catheter into the implanted stent graft for local thrombolysis of tibial arteries if required by the current situation. The patient will be hospitalized at the angiology intensive care unit of the 2nd Medical Department, where local intra-arterial thrombolytic therapy will be performed according to the standard protocol. After completion of the proper endovascular treatment, the patients will be transferred to combined peroral anticoagulation and antiaggregation treatment, and all of them will have an ultrasound scan below the knee, with the readings archived for the purpose of further comparison and monitoring. Subsequently, the patients will be monitored in the outpatient regime after 6 weeks, 3, 6 and 12 months. At each visit, clinical examination will be done including establishment of ABI/TBI values and ultrasound investigation of the region below the knee.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aneurysm; Popliteal Artery Limb Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Combined endovascular approach

Combined endovascular approach using covered stent and flexible stent in the popliteal artery

Group Type EXPERIMENTAL

Combined endovascular approach (EVAR)

Intervention Type PROCEDURE

1. puncture of SFA in orthograde position if possible
2. DSA through 4F dilator, proof of occlusion
3. wire test
4. Heparin 70-80 IU/kg i.a.
5. implantation of peripheral stent graft VIABAHN
6. implantation of peripheral stent SUPERA into stent graft
7. insertion of strait flush catheter for local thrombolysis
8. administration of continuous local thrombolysis in the dose of 1 mg/hr., unfractionated heparin continuously (APTT 1,5-2x) according to the department standards
9. control angiography in 12 hrs or earlier according to clinical status and symptoms
10. repeated angiography in 24 hrs

Standard optimal therapy (OPT)

standard therapy of popliteal artery aneurysm using thrombolysis and surgery

Group Type EXPERIMENTAL

Standard optimal therapy (OPT)

Intervention Type PROCEDURE

1. puncture of SFA in orthograde position if possible
2. DSA through 4F dilator, proof of occlusion
3. wire test
4. Unfractionated heparin 70-80 IU/kg i.a.
5. insertion of strait flush catheter for local thrombolysis
6. administration of continuous local thrombolysis in the dose of 1 mg/hr., unfractionated heparin continuously (APTTT 1,5-2x)
7. control angiography in 12 hrs or according to clinical status and symptoms
8. repeated angiography in24 hrs
9. Final result review, vascular team consultation and indication for surgical or conservative management of popliteal artery aneurysm.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Combined endovascular approach (EVAR)

1. puncture of SFA in orthograde position if possible
2. DSA through 4F dilator, proof of occlusion
3. wire test
4. Heparin 70-80 IU/kg i.a.
5. implantation of peripheral stent graft VIABAHN
6. implantation of peripheral stent SUPERA into stent graft
7. insertion of strait flush catheter for local thrombolysis
8. administration of continuous local thrombolysis in the dose of 1 mg/hr., unfractionated heparin continuously (APTT 1,5-2x) according to the department standards
9. control angiography in 12 hrs or earlier according to clinical status and symptoms
10. repeated angiography in 24 hrs

Intervention Type PROCEDURE

Standard optimal therapy (OPT)

1. puncture of SFA in orthograde position if possible
2. DSA through 4F dilator, proof of occlusion
3. wire test
4. Unfractionated heparin 70-80 IU/kg i.a.
5. insertion of strait flush catheter for local thrombolysis
6. administration of continuous local thrombolysis in the dose of 1 mg/hr., unfractionated heparin continuously (APTTT 1,5-2x)
7. control angiography in 12 hrs or according to clinical status and symptoms
8. repeated angiography in24 hrs
9. Final result review, vascular team consultation and indication for surgical or conservative management of popliteal artery aneurysm.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Signed informed consent form for the patient's participation in the study.
2. Acute critical limb ischaemia with impairment of the extremity at stage I, IIa, IIb according to SVS classification.
3. A popliteal artery aneurysm, confirmed by ultrasound scanning, which on catheterization examination meets the criteria for isolation of the aneurysm sac by implantation of a peripheral stent graft, supported by insertion of a peripheral flexible stent.
4. Absence of any contraindication for local thrombolytic therapy.
5. An anatomic finding through angiographic investigation that is suitable for endovascular therapy.

Exclusion Criteria

1. Active bleeding or contraindication for local thrombolysis.
2. Life expectance \< 1 yr
3. Relevant stenotic defects of valves.
4. Myocardial infarction or unstable angina pectoris in past 3 months.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No